Leuprorelin/norethisterone acetate, also known as leuprolide/norethindrone acetate and sold under the brand name Lupaneta Pack, is a co-packaged medication used to treat endometriosis. It contains leuprorelin as the acetate, a gonadotropin-releasing hormone agonist, and norethisterone acetate, a progestin. The leuprorelin is given by intramuscular injection and the norethisterone acetate is taken by mouth. The co-packaged medication was approved for medical use in the United States in December 2012.
Medical uses Leuprorelin/norethisterone acetate is indicated for the initial management of the painful symptoms of endometriosis and for management of recurrence of symptoms.
References
Further reading Surrey ES (2022). "GnRH agonists in the treatment of symptomatic endometriosis: a review". F&S Reports. 4 (2): 40–45. doi:10.1016/j.xfre.2022.11.009. PMC 10201290. PMID 37223763.
